Elsevier

Medical Hypotheses

Volume 54, Issue 3, March 2000, Pages 456-460
Medical Hypotheses

Regular Article
Resistance of cancer cells to immune recognition and killing

https://doi.org/10.1054/mehy.1999.0876Get rights and content

Abstract

It is well recognized that, in order for a wound to heal, the fibrin clot must be eliminated by fibrinolytic enzymes. In certain instances, however, fibrin is ineffectively degraded or even not degraded. For example, in pregnancy, the placenta contains a layer of fibrin (Nitabuck’s layer) which presents as ‘self’ to the immune system. Similar situations have been observed in many solid tumors. A hypothesis is presented according to which tumor cells can escape detection and attack by the immune system in most cancer patients. The tumor dons a ‘coat’ of the host’s own protein on its cell surface. The coat is composed of fibrin and of a polymeric form of human serum albumin (HSA) which, by contrast to pure fibrin, is resistant to fibrinolytic degradation. Such a coated tumor appears as ‘self’ to the immune system, and thus is not detected as a tumor by the immune system (i.e. natural killer cells). When tumors are prepared for in vitro assays against drugs, they are routinely treated with proteolytic enzymes (e.g. pepsin, or chymotrypsin, etc.) which dissolve the protein coat, exposing the tumor cell surface to the drug. Thus, the in vivo existence of a coat on the tumor surface may explain why some drugs have little or no effect in vivo, while the same drugs are active in vitro.

References (49)

  • A. Gorski et al.

    Depressed immune surveillance against cancer: role of deficient T cell: extracellular matrix interactions

    Cell Adhes Communic

    (1994)
  • I. Cernak et al.

    The possible mechanism of benefit effects of the mature thymic calf extracts (THYMEX-L) in mice bearing a transplanted melanoma

    Interntl J Thymology

    (1996)
  • A.B. Mukherjee et al.

    Possible mechanism of success and allotransplantation in nature: mammalian pregnancy

    Med Hypotheses

    (1980)
  • B. Lipinski et al.

    Fibrinolysis versus fibrinogenolysis of man: resistance of fibrinogen to breakdown by fibrinolytic activity induced by venous occlusion

    Experientia

    (1974)
  • M. Mannick et al.

    Immunoglobulin G and serum albumin isolated from the articular cartilage of patients with rheumatoid arthritis contains covalent heteropolymers with proteoglycans

    Rheumatol Int

    (1993)
  • B. Lipinski

    In vitro preparation and partial characterization of a novel complex of human fibrinogen with albumin

    J Protein Chem

    (1959)
  • B. Lipinski

    Bioelectric theory of pathogenesis of atherosclerosis

    J Bioelectricity

    (1984)
  • B. Lipinski

    Effect of thiol-induced disulfide exchange on plasma clotting and fibrinolysis

    Thromb Haemost

    (1993)
  • B. Lipinski

    Suramin inhibits thrombin induced fibrinogen clotting by forming soluble fibrin complexes

    Thromb Haemost

    (1995)
  • B. Lipinski et al.

    Comments on plasma fibrinogen levels by functional methods

    Thromb Haemost

    (1994)
  • H.F. Dvorak et al.

    Fibrin as a component of the tumor stroma: origins and biological significance

    Cancer Metastasis Rev

    (1983)
  • H. Bardos et al.

    Fibrin deposition in primary and metastatic human brain tumors

    Blood Coagul Fibrinolysis

    (1996)
  • M.Z. Wojtukiewicz et al.

    Fibrinogen–fibrin transformation in situ in renal cell carcinoma

    Anticancer Res

    (1990)
  • S.G. Gordon et al.

    Cancer procoagulant: a factor X activating procoagulant from malignant tissue

    Thromb Res

    (1975)
  • Cited by (13)

    • Networks that stop the flow: A fresh look at fibrin and neutrophil extracellular traps

      2019, Thrombosis Research
      Citation Excerpt :

      These include their own surfaces [153] as well as secreted molecules (such as staphylocoagulase [154]) that induce fibrin polymerization, and proteins that bind fibrin (e.g. protein M [155]). Interestingly, this versatility of approaches are not only seen with external parasites, but also with internal ones: tumor cells have been suggested to use fibrin formation to their advantage possibly by similarly shielding themselves from immune recognition [156], or, in certain cases, inducing fibrinolysis which is thought to help tumor dissemination and metastasis [157]. Citrullination, the conversion of peptidyl-arginyl residues to peptidyl-citrulline via deimination has been in the center of attention in the field of rheumatoid arthritis for a long time (reviewed in [158]), and PAD enzymes responsible for this irreversible post-translational modification have been extensively investigated.

    • Pathophysiological significance of protein hydrophobic interactions: An emerging hypothesis

      2018, Medical Hypotheses
      Citation Excerpt :

      These findings indicate that the immune therapy is directed not so much at stimulating the immune system of a host, but at improving the surveillance capability of the cellular defense system. The proposed mechanism of this type of therapy is based on a strong interaction between the hydrophobic regions of fibrin–albumin coat on tumor cells and the apolar side chains of a superantigen [50]. As a result, such sandwiched cells become 'non-self ' and are subsequently recognized and attacked by natural killer (NK) cells.

    • Differential regulation of macrophage inflammatory activation by fibrin and fibrinogen

      2017, Acta Biomaterialia
      Citation Excerpt :

      In cancer, fibrinogen is thought to play a role in metastasis, since lack of fibrinogen has been shown to diminish tumor metastasis [62,63]. Fibrin is found within tumor tissues [64] and may prevent macrophage inflammatory activation to promote tumor survival. In cardiovascular disease, increased plasma levels of fibrinogen and fibrin degradation products are associated with disease progression [65–68], and these molecules, in addition to fibrin, are found within atherosclerotic lesions but not in normal healthy vessels [69].

    • The prothrombotic activity of cancer cells in the circulation

      2016, Blood Reviews
      Citation Excerpt :

      Perhaps TF expression confers a survival advantage to cancer cells in the circulation. Indeed, inhibition of TF, FXa or thrombin has been shown to prevent the formation of metastatic niches in SCID mice bearing human melanoma tumors [41–43]. Similarly, C57Bl/6 mice injected with highly metastatic tumor cells devoid of TF were protected from metastatic disease [44].

    • Bromelain's activity and potential as an anti-cancer agent: Current evidence and perspectives

      2010, Cancer Letters
      Citation Excerpt :

      Additionally, tumor cells are believed to form a protective coat by polymerizing fibrin and human serum albumin. This coat is resistant to the proteolytic activity of internal proteases such as plasmin and provides tumor cells with protection against the immune system [73]. A recent study of the thrombin receptor expression in primary tumor cells [74] can provide an insight into the molecular mechanisms of such coat formation.

    View all citing articles on Scopus
    View full text